semaglutide compound deaths Compounded' weight-loss drugs are a growing problem for state regulators • Stateline Compounded Semaglutide Safety: What You

"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Eli Lilly and Company , 11 Dec

So, GLP-1 agonist medications could worsen the symptoms of gastroparesis by keeping food in the stomach even longer

Two of the most talked-about treatments are retatrutide and tirzepatide, both showing significant results in weight management

Specifically, 0.2% of patients in the GLP-1 RA group developed nAMD, compared with 0.1% in the unexposed group

Others dismiss them as overpriced multivitamins wrapped in trendy marketing

Appetite suppression and under-eating A smaller appetite may sound ideal at first, but too little appetite can quickly become a problem if it stops you eating enough to support your energy, mood, and muscle mass